Physician profile
Scott Salmon
NPI 1063687051
$3,296.22
in general payments reported to CMS, 2019-2025
14 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $20.72 · 2021: $73.51 · 2022: $44.67 · 2024: $2,635 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $941 · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $941.27 |
| Food and Beverage | $388.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,666.37 | 2019-2024 | |
| Boston Scientific Corporation | $212.27 | 2019-2025 | Lithovue |
| Coloplast Corp | $74.79 | 2019-2021 | |
| Procept Biorobotics Corporation | $71.73 | 2025 | |
| Janssen Biotech, INC. | $42.73 | 2019 | |
| Endo Pharmaceuticals INC. | $34.63 | 2019 | |
| 180 Medical, INC. | $33.79 | 2019-2020 | |
| Abbvie INC. | $32.37 | 2024 | |
| Astellas Pharma US INC | $27.95 | 2019 | |
| Merck Sharp & Dohme LLC | $25.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $24.55 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $20.26 | 2019 | |
| Travere Therapeutics, INC. | $15.28 | 2019 | |
| Blue Earth Diagnostics | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Salmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.